Coptis chinensis

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Coptis chinensis has been used for the treatment of inflammatory diseases in China and other Asian countries for centuries… (More)
Is this relevant?
2013
2013
ETHNOPHARMACOLOGICAL RELEVANCE Rhizoma coptidis (RC) has been used as a remedy for inflammation-related diseases in traditional… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2012
2012
OBJECTIVE To separate and identify chemical constituents from Coptis chinensis. METHOD The compounds were separated and… (More)
Is this relevant?
2011
2011
Coptis chinensis has been used in traditional Chinese medicine to treat inflammatory symptoms. Berberine is the main alkaloid… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Berberine (BBR) is a compound originally identified in a Chinese herbal medicine Huanglian (Coptis chinensis French). It improves… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2011
2011
The Chinese formula Tang-Min-Ling (TML), an improved product of the decoction of Dachaihu which has a history of more than 2000… (More)
Is this relevant?
2009
2009
Conventional chemotherapy of liver cancer fails to provide satisfactory remission and may cause serious side effects, thus it is… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2009
2009
Radix Scutellariae (RS) and Coptis Chinensis (CC) are the most popular components in traditional Chinese medicine prescriptions… (More)
Is this relevant?
2004
2004
1. The present study was conducted to evaluate the cytotoxic effects of Coptis chinensis and Epimedium sagittatum extracts and… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
The antioxidative and superoxide- and hydroxyl radical-scavenging activities and pro-oxidant effect of twelve selected medicinal… (More)
Is this relevant?